Cat. #154776
Anti-Ig/BCR [M2B3]
Cat. #: 154776
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Ig/BCR
Class: Monoclonal
Application: FACS ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Netherlands Cancer Institute
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-Ig/BCR [M2B3]
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IP
- Description: The B-cell receptor (BCR) is composed of immunoglobulin molecules that form a type 1 transmembrane receptor protein usually located on the outer surface of B cells. Through biochemical signalling and by physically acquiring antigens from the immune synapses, the BCR controls the activation of B-cell.
- Immunogen: B cell non-Hodgkin's lymphoma
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: Ig/BCR
- Target background: The B-cell receptor (BCR) is composed of immunoglobulin molecules that form a type 1 transmembrane receptor protein usually located on the outer surface of B cells. Through biochemical signalling and by physically acquiring antigens from the immune synapses, the BCR controls the activation of B-cell.
Applications
- Application: FACS ; IP
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
